U.S. Health Care System Compared to Other Countries
This paper compares the health care systems of the United States, United Kingdom, Japan, France, and India across eight dimensions: coverage, funding, costs, providers, integration, markets, supply, and patient satisfaction. It also examines the role of government, system strengths, and system weaknesses in each country. While the U.S. incurs the highest administrative and per-person costs, its long-term care spending is comparatively low among developed nations. The analysis finds that single-payer systems in the UK and Japan achieve broader coverage but face longer wait times, while the U.S. mixed market allows provider choice but leaves vulnerable populations without adequate access.
- Introduction: Framing the five-country health care comparison
- Coverage and Funding: Public vs. private coverage and funding sources
- Costs and Providers: Administrative costs, long-term care, and provider choice
- Integration and Markets: Integrated care access and market structure
- Supply and Patient Satisfaction: Care access, APRN laws, and satisfaction rankings
- Government Role, System Strengths, and Weaknesses: Regulatory roles, competitive strengths, and cost barriers
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- Uses a consistent comparative framework — evaluating each country across the same set of dimensions — which makes the analysis easy to follow and prevents cherry-picking.
- Grounds cost comparisons in an important methodological caveat (administrative vs. long-term care costs, and the hidden tax burden of universal systems), which shows critical thinking about statistics.
- Balances breadth (five countries, ten dimensions) with enough specificity (e.g., APRN scope-of-practice laws constraining supply) to support concrete conclusions.
Key academic technique demonstrated
The paper demonstrates systematic comparative analysis: rather than evaluating each country in isolation, it applies identical criteria to all five systems and draws cross-national conclusions. This structure allows the reader to see patterns — such as the trade-off between universal access and wait times — that would be invisible in a single-country study.
Structure breakdown
The paper opens with an introductory framing paragraph, then moves through ten thematic sections (Coverage, Funding, Costs, Providers, Integration, Markets, Analysis, Supply, Satisfaction, Role of the Government) before concluding with paired Strengths and Weaknesses sections. Each thematic section addresses all five countries in turn, creating a grid-like comparative structure supported by WHO, CMS, and Peterson Foundation data.
Introduction
The U.S. health care system compares favorably to some other countries in terms of long-term costs but unfavorably to others in terms of quality of care. Statistics about costs can be misleading, however, because there are administrative costs and long-term care costs to consider, as well as taxpayer costs in countries like the UK and Japan, where health care has been nationalized. Household expenses may appear high in the U.S., but in the UK they are also high when one takes into consideration how heavily citizens are taxed to pay for universal coverage. This paper compares the health care systems of the United States, United Kingdom, Japan, France, and India to assess how well each system performs across a range of key dimensions.
Coverage and Funding
Coverage
Coverage in the U.S. is both private and public. The government provides coverage for individuals through Medicare and Medicaid if they meet an age or income threshold. France operates a mix of public and private coverage but skews mainly toward public care, with a universal system recently put in place. In India, coverage is primarily private, with only 20% coming from the government — the opposite of France (WHO, 2018).
In the UK, coverage is public, though individuals can pay out of pocket for private or home care. Japan operates similarly, with universal coverage as the baseline and private coverage available as an option.
Funding
In the U.S., funding comes from taxpayers who support Medicare and Medicaid, but it also comes from private insurers funded by individuals or by companies that offer health benefits as employee incentives. In the UK, funding comes entirely from taxpayers, as it does in Japan. In France, funding is mixed, as in the U.S. In India, funding is primarily from individuals, with some government contributions from taxpayers (WHO, 2018).
Create your account
Always verify citation format against your institution’s current style guide requirements.